Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5-Fluoroindole propanol phosphate is a synthetic small molecule belonging to the class of 3‑alkylindoles, characterized by an indole core substituted with a fluorine atom and a propanol phosphate side chain. It is primarily used as an experimental biochemical tool and not as an approved pharmaceutical agent. The compound acts as an inhibitor at the alpha site of tryptophan synthase, interfering with the enzyme's function in tryptophan biosynthesis. Its structure allows it to bind specifically to the alpha subunit of tryptophan synthase, stabilizing certain conformational states and providing insight into allosteric regulation mechanisms within this enzyme complex[8][9]. There are no known clinical indications or therapeutic uses for this compound; its main application is in structural biology and enzymology research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 5-fluoroindole propanol phosphate.